This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Nippon Zoki Pharmaceutical Co., Ltd., Dyax Corporation, Takeda Pharmaceutical Company Limited. Active years: 2000-2024.
Company Filing History:
2 out of 148 
1 out of 174 
1 out of 1,226 
Years Active: 2000-2024
Title: The Innovative Contributions of Allen P Kaplan
Introduction
Allen P Kaplan, an esteemed inventor based in Charleston, SC, has made significant strides in the field of biomedical innovations. With a remarkable portfolio encompassing four patents, his work focuses on addressing critical health challenges associated with plasma protease disorders. Kaplan's inventions notably contribute to improving diagnostic methods and treatment options for various medical conditions.
Latest Patents
Kaplan's latest patents revolve around the evaluation, assays, and treatment of pKal-mediated disorders. One of his inventions presents assay methods for detecting plasma protease C1 inhibitor (C1-INH) that interacts with plasma kallikrein and Factor XII. These methods are instrumental in identifying subjects who are at risk of or suffering from pKal-mediated or bradykinin-mediated disorders. His research includes methods that facilitate the assessment of patients with plasma kallikrein-mediated angioedema (KMA) and other related diseases, thereby enhancing the tools available for evaluation and treatment.
Career Highlights
Throughout his career, Kaplan has held pivotal positions in notable companies within the pharmaceutical industry. He has worked with Nippon Zoki Pharmaceutical Company and Dyax Corporation, where he contributed to various innovative projects that push the boundaries of medical science. His focus on developing new methods to assist in the management of complex disorders showcases his commitment to advancing healthcare solutions.
Collaborations
In his journey as an inventor, Kaplan has collaborated with distinguished professionals, including Kusumam Joseph and Yoji Shibayama. These collaborations have likely enriched his research and led to the development of groundbreaking technologies aimed at improving patient outcomes through innovative medical solutions.
Conclusion
Allen P Kaplan's work epitomizes the spirit of innovation in the biomedical field. His contributions, particularly in the area of plasma protease disorders, highlight the vital role of inventors in tackling complex medical challenges. As we continue to explore the world of inventions, Kaplan's legacy will inspire future innovations that aim to improve health and well-being for many.